FICORELLA, Corrado
 Distribuzione geografica
Continente #
NA - Nord America 143
AS - Asia 81
EU - Europa 39
SA - Sud America 9
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 275
Nazione #
US - Stati Uniti d'America 139
SG - Singapore 42
IT - Italia 14
CN - Cina 11
VN - Vietnam 10
IN - India 8
BR - Brasile 6
DE - Germania 6
SE - Svezia 6
PL - Polonia 3
CA - Canada 2
GB - Regno Unito 2
HK - Hong Kong 2
IQ - Iraq 2
JP - Giappone 2
MX - Messico 2
NL - Olanda 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
AR - Argentina 1
BE - Belgio 1
CH - Svizzera 1
CO - Colombia 1
ES - Italia 1
EU - Europa 1
FI - Finlandia 1
IR - Iran 1
MA - Marocco 1
RU - Federazione Russa 1
SN - Senegal 1
UA - Ucraina 1
VE - Venezuela 1
Totale 275
Città #
San Jose 26
Singapore 20
Ashburn 15
Chandler 7
Bengaluru 6
Hefei 6
Ho Chi Minh City 6
Lawrence 6
Munich 6
Princeton 6
Santa Clara 6
Dallas 5
Milan 5
Beijing 3
Chicago 3
Los Angeles 3
Baghdad 2
Des Moines 2
Hong Kong 2
London 2
New York 2
Phoenix 2
Poznan 2
Redwood City 2
Rome 2
Stockholm 2
The Dalles 2
Wilmington 2
Alfenas 1
Amsterdam 1
Atlanta 1
Boardman 1
Bogotá 1
Boston 1
Buenos Aires 1
Buffalo 1
Bắc Ninh 1
Campinas 1
Charlotte 1
Charlottesville 1
Clearwater 1
Dakar 1
Dammam 1
Ecatepec 1
Hyderabad 1
Hải Dương 1
Kabul 1
Maracaibo 1
Mexico City 1
Montreal 1
Naples 1
New Delhi 1
Norwalk 1
Pisa 1
Pittsburgh 1
Providence 1
Redmond 1
Riyadh 1
San Francisco 1
St Petersburg 1
São José dos Campos 1
Thuận An 1
Timóteo 1
Turku 1
Tétouan 1
Votorantim 1
Warsaw 1
Zurich 1
Totale 193
Nome #
Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer 84
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 54
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 40
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 37
Second-line eribulin in triple negative metastatic breast cancer patients. Multicentre retrospective study: The tetris trial 37
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 32
Totale 284
Categoria #
all - tutte 3.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202219 0 1 0 4 0 1 3 1 2 2 4 1
2022/202334 12 1 1 0 2 3 2 2 5 0 5 1
2023/202429 8 7 2 5 1 2 1 0 0 1 1 1
2024/202558 11 0 5 1 3 11 2 0 4 1 10 10
2025/2026136 10 20 10 7 24 13 16 8 19 6 3 0
Totale 284